DOI: 10.1055/s-00000036

Laryngo-Rhino-Otologie

References

Daud AI, Wolchok JD, Robert C. et al.
Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma.

J Clin Oncol 2016;
34: 4102-4109

Download Bibliographical Data

Access:
Access: